Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome

NCT01071044 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Chronic Fatigue Syndrome
Cognitive Impairments

Interventions

DRUG: Lisdexamfetamine Dimesylate
DRUG: Placebo "30, 50 or 70 mg"

Sponsor

Rochester Center for Behavioral Medicine

Collaborators

[object Object]